Feasibility study of oral medication administration of Myrtol Standardized Enteric Capsules after meal

The effects of meal on oral absorption and bioavailablity of Myrtol Standardized Enteric Capsules

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15005849

Enrollment

Unknown

Registered

2015-01-18

Start date

2013-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

excessive phlegm

Interventions

One cohort:Myrtol Standardized Enteric Capsules

Eligibility

Sex/Gender

Male

Age

18 Years to 38 Years

Inclusion criteria

Inclusion criteria: Male healthy Chinese volunteers were recuited in this study (age range, 18-40years; BMI range, 19-25 kg/m2). All volunteers gave their written informed consent. They were determined to be healthy by a medical history, a physical examination, electrocardiogram, and laboratory tests (including complete blood count, blood biochemistry testing and urinalysis) before starting this study. They should not be smokers, alcoholists or drug abusers.

Exclusion criteria

Exclusion criteria: Participants were excluded for the following reasons: any significant medical history; history of any localized or systemic infectious within 4 wks before admission; use of prescription or over-the counter medication or alcohol within 2 wks before enrollment; history of smoking, alcohol or drug abuse; donation of blood within the past 1 month; participation in clinical trial within the past 2 months.

Design outcomes

Primary

Measure	Time frame
oral absorption and bioavailablity;	—

Contacts

Public ContactLing-ling Zhu

zhouquan142602@zju.edu.cn+86 13588428777

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026